Reversal of chaperone activity loss of glycated αA-crystallin by a crosslink breaker

Molecular and Cellular Biochemistry

Volumn 315, Issue 1-2, 2008, Pages 137-142

  Datta, Poppy ^a   Kallur, Latha ^a   Abraham, Edathara C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

A crystallin; Chaperone; Crosslinking; Glycation; Thiazolium compounds

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALCOHOL DEHYDROGENASE; ALPHA CRYSTALLIN; BROMINE DERIVATIVE; CHAPERONE; GLUCOSE 6 PHOSPHATE; N PHENACYL 4,5 DIMETHYLTHIAZOLIUM BROMIDE; RECOMBINANT ALPHA CRYSTALLIN; RECOMBINANT PROTEIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; FLUORESCENCE ANALYSIS; GEL PERMEATION CHROMATOGRAPHY; HUMAN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; PROTEIN STABILITY;

ALPHA-CRYSTALLIN A CHAIN; CROSS-LINKING REAGENTS; GLUCOSE-6-PHOSPHATE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; SPECTROMETRY, FLUORESCENCE; THIAZOLES; TIME FACTORS; TRYPTOPHAN;

ESCHERICHIA COLI;

EID: 46749107997     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9797-2     Document Type: Article

References (25)

1. Horwitz J (1992) α-Crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA 89:10449-10453. doi: 10.1073/ pnas.89.21.10449
2. Horwitz J, Emmons T, Takemoto L (1992) The ability of lens α-crystallin to protect against heat-induced aggregation is age dependent. Curr Eye Res 8:817-822. doi: 10.3109/02713689209000754
3. Shroff NP, Cherian-Shaw M, Bera S et al (2000) Mutation of R116C results in highly oligomerized αA-crystallin with modified structure and defective chaperone-like function. Biochemistry 39:1420-1426. doi: 10.1021/bi991656b
4. Kelley PB, Abraham EC (2003) Thermally induced disintegration of the oligomeric structure of αB-crytstallin mutant F28S is associated with diminished chaperone activity. Mol Cell Biochem 252:273-278. doi: 10.1023/A:1025568417000
5. Monnier VM (1989) Toward a Maillard reaction theory of aging. In: Baynes JW, Monnier VM (eds) Maillard reaction in aging, diabetes and nutrition. Alan R. Liss, New York, pp 1-22
6. Perry RE, Swamy MS, Abraham EC (1987) Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. Exp Eye Res 44:269-282. doi: 10.1016/S0014-4835(87)80011-8
7. Swamy MS, Abraham EC (1987) Lens protein composition, glycation, and high molecular weight aggregation in aging rats. Invest Ophthalmol Vis Sci 28:1693-1701
8. Brownlee M, Vlassara H, Cerami A (1984) Non-enzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537
9. Abraham EC, Swamy MS, Perry RE (1989) Non-enzymatic glycosylation (glycation) of lens crystallins in diabetes and aging. In: Baynes JW, Monnier VM (eds) Maillard reaction in diabetes, aging, and nutrition, Alan R. Liss, New York, pp 123-139
10. Swamy MS, Tsai C, Abraham EC (1993) Glycation mediated lens crystallin aggregation and cross-linking by various sugars and sugar phosphates in vitro. Exp Eye Res 56:177-185. doi: 10.1006/exer.1993.1025
11. Vasan S, Zhang X, Zhang X et al (1996) An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382:275-278. doi: 10.1038/382275a0
12. Wolffenbuttel BH, Boulanger CM, Crijns FR et al (1998) Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95:4630-4634. doi: 10.1073/ pnas.95.8.4630
13. Cooper ME, Thallas V, Forbes J et al (2000) The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation. Diabetologia 43:660-664. doi: 10.1007/ s001250051355
14. Oturai PS, Christensen M, Rolin B et al (2000) Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats. Metabolism 49:996-1000. doi: 10.1053/meta.2000.7731
15. Vaitkevicius PV, Lane M, Spurgeon H et al (2001) A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci USA 98:1171-1175. doi: 10.1073/ pnas.98.3.1171
16. Hollenbach S, Thampi P, Viswanathan T et al (2003) Cleavage of in vitro and in vivo formed lens protein cross-links by a novel cross-link breaker. Mol Cell Biochem 243:73-80. doi: 10.1023/A:1021660105893
17. Cherian M, Abraham EC (1995) Diabetes affects α-crystallin chaperone function. Biochem Biophys Res Commun 212:184-189. doi: 10.1006/ bbrc.1995.1954
18. Thampi P, Zarina S, Abraham EC (2002) α-Crystallin chaperone function in diabetic rat and human lenses. Mol Cell Biochem 229:113-118. doi: 10.1023/A:1017980713089
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. doi: 10.1038/227680a0
20. Bera S, Abraham EC (2002) The αA-crystallin R116C mutant has a higher affinity for forming heteroaggregates with αB-crystallin. Biochemistry 41:297-305. doi: 10.1021/bi011010v
21. Aziz A, Santhoshkumar P, Sharma KK et al (2007) Cleavage of the C-terminal serine of human αA-crystallin produces αA1-172 with increased chaperone activity and oligomeric size. Biochemistry 46:2510-2519. doi: 10.1021/bi0618722
22. Swamy MS, Abraham EC (1992) Glycation of lens membrane intrinsic proteins. Curr Eye Res 11:833-842. doi: 10.3109/02713689209033481
23. Thornalley PJ, Minhas HS (1999) Rapid hydrolysis and slow alpha-beta dicarbonyl cleavage of a compound proposed to cleavage glucose-derived protein crosslinks. Biochem Pharmacol 1:3003-3007
24. Cheng HM, Chylack LT, Von Saltza (1981) Supplementing glucose metabolism in human senile cataracts. Invest Ophthalmol Vis Sci 21:812-818
25. Yang S, Litchfield JE, Baynes JW (2003) AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats. Arch Biochem Biophys 412:42-46. doi: 10.1016/S0003-9861(03)00015-8